Literature DB >> 25403246

Paediatrics: Transgender medicine--long-term outcomes from 'the Dutch model'.

Daniel E Shumer1, Norman P Spack1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25403246      PMCID： PMC4349440          DOI： 10.1038/nrurol.2014.316

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  4 in total

1.  Pubertal delay as an aid in diagnosis and treatment of a transsexual adolescent.

Authors:  P T Cohen-Kettenis; S H van Goozen
Journal:  Eur Child Adolesc Psychiatry       Date:  1998-12       Impact factor: 4.785

2.  Young adult psychological outcome after puberty suppression and gender reassignment.

Authors:  Annelou L C de Vries; Jenifer K McGuire; Thomas D Steensma; Eva C F Wagenaar; Theo A H Doreleijers; Peggy T Cohen-Kettenis
Journal:  Pediatrics       Date:  2014-09-08       Impact factor: 7.124

3.  Mortality and morbidity in transsexual subjects treated with cross-sex hormones.

Authors:  P J van Kesteren; H Asscheman; J A Megens; L J Gooren
Journal:  Clin Endocrinol (Oxf)       Date:  1997-09       Impact factor: 3.478

4.  Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline.

Authors:  Wylie C Hembree; Peggy Cohen-Kettenis; Henriette A Delemarre-van de Waal; Louis J Gooren; Walter J Meyer; Norman P Spack; Vin Tangpricha; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2009-06-09       Impact factor: 5.958
  4 in total
  2 in total

Review 1.  Gender dysphoria in adolescence: current perspectives.

Authors:  Riittakerttu Kaltiala-Heino; Hannah Bergman; Marja Työläjärvi; Louise Frisén
Journal:  Adolesc Health Med Ther       Date:  2018-03-02

2.  Re-evaluation of the Dutch approach: are recently referred transgender youth different compared to earlier referrals?

Authors:  Marijn Arnoldussen; Thomas D Steensma; Arne Popma; Anna I R van der Miesen; Jos W R Twisk; Annelou L C de Vries
Journal:  Eur Child Adolesc Psychiatry       Date:  2019-08-31       Impact factor: 4.785
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.